20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
Why is it that most mergers, reorganizations, and downsizings fail to generate their anticipated full value? The main reason is that a lack of effective…
Read more
As the traditional levers of value creation get price-in, getting a competitive edge in private equity lies in unlocking hidden potential within portfolio companies through…
Read more
According to the most recent federal statistics, business bankruptcy filings surged by 33% in the US between September 2023 and September 2024. Elevated debt, higher supplier costs,…
Read more
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
